Stockholm Stock Exchange | Small Cap
Alligator
+525.00%
Latest
-
3 months
DNB Markets

Price Targets

Latest price targets per analyst.

AnalystPrice TargetDateUpside
DNB Markets10 SEKJul -21
+525.00%

About The Company

Alligator Bioscience is developing antibody-based drugs for the treatment of cancer. The company specializes in the development of tumor-targeted immunotherapies, in particular agonist mono- and bispecific antibodies, and is active in the early stages of drug development, from concept to phase II clinical trials. Alligator was founded in 2001 and is located at Medicon Village in Lund, Sweden.
Alligator